Literature DB >> 24940157

P-glycoprotein Expression and Pharmacoresistant Epilepsy: Cause or Consequence?

Barry E Gidal.   

Abstract

Entities:  

Year:  2014        PMID： 24940157      PMCID： PMC4038278          DOI： 10.5698/1535-7597-14.3.136

Source DB:  PubMed          Journal:  Epilepsy Curr        ISSN： 1535-7511            Impact factor:   7.500


× No keyword cloud information.
  17 in total

1.  P-glycoprotein expression and antiepileptic drug resistance.

Authors:  Jacqueline A French
Journal:  Lancet Neurol       Date:  2013-06-18       Impact factor: 44.182

2.  Distribution and functional activity of P-glycoprotein and multidrug resistance-associated proteins in human brain microvascular endothelial cells in hippocampal sclerosis.

Authors:  Hisashi Kubota; Hideyuki Ishihara; Thomas Langmann; Gerd Schmitz; Bruno Stieger; Heinz-Gregor Wieser; Yasuhiro Yonekawa; Karl Frei
Journal:  Epilepsy Res       Date:  2005-12-19       Impact factor: 3.045

Review 3.  Drug-resistant epilepsy.

Authors:  Patrick Kwan; Steven C Schachter; Martin J Brodie
Journal:  N Engl J Med       Date:  2011-09-08       Impact factor: 91.245

Review 4.  The multidrug transporter P-glycoprotein in pharmacoresistance to antiepileptic drugs.

Authors:  Karolina M Stępień; Michał Tomaszewski; Joanna Tomaszewska; Stanisław J Czuczwar
Journal:  Pharmacol Rep       Date:  2012       Impact factor: 3.024

5.  Drug resistance in epilepsy: expression of drug resistance proteins in common causes of refractory epilepsy.

Authors:  S M Sisodiya; W-R Lin; B N Harding; M V Squier; M Thom
Journal:  Brain       Date:  2002-01       Impact factor: 13.501

6.  Neuropathology of the blood-brain barrier and pharmaco-resistance in human epilepsy.

Authors:  Joan Y W Liu; Maria Thom; Claudia B Catarino; Lillian Martinian; Dominique Figarella-Branger; Fabrice Bartolomei; Matthias Koepp; Sanjay M Sisodiya
Journal:  Brain       Date:  2012-06-28       Impact factor: 13.501

7.  Induction of P-glycoprotein in lymphocytes by carbamazepine and rifampicin: the role of nuclear hormone response elements.

Authors:  Andrew Owen; Chris Goldring; Paul Morgan; B Kevin Park; Munir Pirmohamed
Journal:  Br J Clin Pharmacol       Date:  2006-08       Impact factor: 4.335

8.  Exposure to antiepileptic drugs does not alter the functionality of P-glycoprotein in brain capillary endothelial and kidney cell lines.

Authors:  Kamila Ambroziak; Konstantin Kuteykin-Teplyakov; Carlos Luna-Tórtos; Marwan Al-Falah; Maren Fedrowitz; Wolfgang Löscher
Journal:  Eur J Pharmacol       Date:  2009-12-01       Impact factor: 4.432

9.  Induction of nuclear receptors and drug resistance in the brain microvascular endothelial cells treated with antiepileptic drugs.

Authors:  Laura Lombardo; Rosalia Pellitteri; Michael Balazy; Venera Cardile
Journal:  Curr Neurovasc Res       Date:  2008-05       Impact factor: 1.990

10.  MDR1 gene expression in brain of patients with medically intractable epilepsy.

Authors:  D M Tishler; K I Weinberg; D R Hinton; N Barbaro; G M Annett; C Raffel
Journal:  Epilepsia       Date:  1995-01       Impact factor: 5.864
View more
  4 in total

Review 1.  Breaking Bad: the Structure and Function of the Blood-Brain Barrier in Epilepsy.

Authors:  Hadas Han; Aniv Mann; Dana Ekstein; Sara Eyal
Journal:  AAPS J       Date:  2017-05-26       Impact factor: 4.009

2.  Inhibition of mTOR Pathway by Rapamycin Decreases P-glycoprotein Expression and Spontaneous Seizures in Pharmacoresistant Epilepsy.

Authors:  Xiaosa Chi; Cheng Huang; Rui Li; Wei Wang; Mengqian Wu; Jinmei Li; Dong Zhou
Journal:  J Mol Neurosci       Date:  2017-02-22       Impact factor: 3.444

3.  Cytosolic phospholipase A2 is a key regulator of blood-brain barrier function in epilepsy.

Authors:  Anika M S Hartz; Ralf G Rempe; Emma L B Soldner; Anton Pekcec; Juli Schlichtiger; Richard Kryscio; Bjoern Bauer
Journal:  FASEB J       Date:  2019-10-29       Impact factor: 5.834

Review 4.  Advances of Molecular Imaging in Epilepsy.

Authors:  Marian Galovic; Matthias Koepp
Journal:  Curr Neurol Neurosci Rep       Date:  2016-06       Impact factor: 5.081
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.